An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing Regimens

ClinicalTrials.gov ID: NCT01168856

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01168856. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:56 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Long-term Monitoring Study to Evaluate the Persistence of Direct Antiviral (DAA) Treatment Resistant Mutations or the Durability of Sustained Virological Response (SVR) in Patients Treated With DAA Containing Regimens for Chronic Hepatitis C Infections (CHC)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This observational long-term follow-up study will assess the persistence of direct acting antiviral (DAA) resistant mutations and the durability of sustained virological response in patients with chronic hepatitis C who have participated in a Roche DAA treatment protocol. Up to 5 scheduled monitoring visits for blood sampling during an observational period of up to 36 months.

Study identification

NCT ID: NCT01168856
Recruitment status: Terminated
Study type: Observational
Phase: Not listed
Lead sponsor: Hoffmann-La Roche; Industry
Enrollment: 734 participants

Conditions and interventions

Conditions

Hepatitis C, Chronic

Interventions

Not listed

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 2010 (Type not available)
Primary completion: Apr 2015 (Actual)
Completion: Apr 2015 (Actual)
Last update posted: Mar 11, 2016

2010 – 2015

United States locations

U.S. sites: 34
U.S. states: 19
U.S. cities: 31

Facility	City	State	ZIP	Site status
Not listed	La Jolla	California	92037-1030	—
Not listed	Long Beach	California	90822	—
Not listed	Sacramento	California	95817	—
Not listed	Sacramento	California	95825	—
Not listed	San Diego	California	92103-8465	—
Not listed	San Francisco	California	94115	—
Not listed	Aurora	Colorado	80045	—
Not listed	Englewood	Colorado	80113	—
Not listed	Bradenton	Florida	34209	—
Not listed	Atlanta	Georgia	30309	—
Not listed	Decatur	Georgia	30033	—
Not listed	Marietta	Georgia	30060	—
Not listed	Honolulu	Hawaii	96814	—
Not listed	Chicago	Illinois	60637	—
Not listed	Indianapolis	Indiana	46202	—
Not listed	Kansas City	Kansas	66160-7222	—
Not listed	New Orleans	Louisiana	70112	—
Not listed	Detroit	Michigan	48202	—
Not listed	Kansas City	Missouri	64131	—
Not listed	Lebanon	New Hampshire	03756	—
Not listed	Hillsborough	New Jersey	08844	—
Not listed	Newark	New Jersey	07102	—
Not listed	Manhasset	New York	11030	—
Not listed	New York	New York	10003	—
Not listed	New York	New York	10021	—
Not listed	Providence	Rhode Island	02905	—
Not listed	Nashville	Tennessee	37211	—
Not listed	Dallas	Texas	75246	—
Not listed	Houston	Texas	77030	—
Not listed	San Antonio	Texas	78212	—
Not listed	San Antonio	Texas	78234	—
Not listed	Newport News	Virginia	23602	—
Not listed	Richmond	Virginia	23249	—
Not listed	Vancouver	Washington	98604	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 92 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01168856, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 11, 2016 · Synced Nov 15, 2026